PTGES2
Prostaglandin E synthase 2
Also known as: C9orf15, FLJ14038, PGES2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H7Z7
- Gene
- PTGES2
- Ensembl
- ENSG00000148334
- Chromosome
- 9
- Canonical length
- 377 aa
- Protein class
- Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a membrane-associated prostaglandin E synthase, which catalyzes the conversion of prostaglandin H2 to prostaglandin E2. This protein also has been shown to activate the transcription regulated by a gamma-interferon-activated transcription element (GATE). Multiple transcript variants have been found for this gene. [provided by RefSeq, Jun 2009]
Canonical amino-acid sequenceUniProt
377 residues, UniProt reviewed canonical sequence.
>Q9H7Z7|PTGES2
1 MDPAARVVRA LWPGGCALAW RLGGRPQPLL PTQSRAGFAG AAGGPSPVAA ARKGSPRLLG
61 AAALALGGAL GLYHTARWHL RAQDLHAERS AAQLSLSSRL QLTLYQYKTC PFCSKVRAFL
121 DFHALPYQVV EVNPVRRAEI KFSSYRKVPI LVAQEGESSQ QLNDSSVIIS ALKTYLVSGQ
181 PLEEIITYYP AMKAVNEQGK EVTEFGNKYW LMLNEKEAQQ VYGGKEARTE EMKWRQWADD
241 WLVHLISPNV YRTPTEALAS FDYIVREGKF GAVEGAVAKY MGAAAMYLIS KRLKSRHRLQ
301 DNVREDLYEA ADKWVAAVGK DRPFMGGQKP NLADLAVYGV LRVMEGLDAF DDLMQHTHIQ
361 PWYLRVERAI TEASPAHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTGES2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 131 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 131 nTPM
- heart muscle: 100 nTPM
- tongue: 74 nTPM
- cerebral cortex: 66 nTPM
- hippocampal formation: 56 nTPM
- adrenal gland: 56 nTPM
Single-cell type
- gastric progenitor cells: 142 nCPM
- esophageal basal cells: 123 nCPM
- esophageal suprabasal cells: 107 nCPM
- cytotrophoblasts: 101 nCPM
- enteric transient amplifying cells: 98 nCPM
- colonocytes: 92 nCPM
Immune cell
- plasmacytoid DC: 5.8 nTPM
- myeloid DC: 4.3 nTPM
- MAIT T-cell: 3.8 nTPM
- memory B-cell: 3.8 nTPM
- intermediate monocyte: 3.7 nTPM
- memory CD8 T-cell: 3.5 nTPM
Brain region
- cerebral cortex: 53 nTPM
- hippocampal formation: 49 nTPM
- basal ganglia: 44 nTPM
- hypothalamus: 44 nTPM
- choroid plexus: 42 nTPM
- pons: 42 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.9
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cyclooxygenase pathway
- lipid metabolic process
- positive regulation of DNA-templated transcription
- prostanoid biosynthetic process
- secretion
Molecular functions
- 12-hydroxyheptadecatrienoic acid synthase activity
- DNA binding
- glutathione binding
- heme binding
- lyase activity
- prostaglandin-E synthase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glutathione S-transferase, N-terminal
- Glutathione S-transferase, C-terminal-like
- Thioredoxin-like superfamily
- Glutathione S-transferase, C-terminal domain superfamily
- Glutathione transferase family
- Glutathione S-transferase, N-terminal domain
- Prostaglandin E synthase 2
- Prostaglandin E synthase 2, C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTGES2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTGES2 as an antibody target. Whether an autoantibody or antibody against PTGES2 could matter depends on whether native PTGES2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTGES2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PTGES2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...